Emergence of SARS-CoV-2 resistance mutations in a patient who received anti-SARS-COV2 spike protein monoclonal antibodies: a case report

To manage severe or potentially severe cases of CoronaVirus Disease 2019 (COVID-19), therapeutic monoclonal antibodies targeting Spike protein of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) ha...

Source: BMC Infectious Diseases - December 7, 2021 Category: Infectious Diseases Authors: Honorine Fenaux, Romain Gueneau, Amal Chaghouri, Beno ît Henry, Lina Mouna, Anne-Marie Roque-Afonso and Christelle Vauloup-Fellous Tags: Case report Source Type: research